Pharma Archives - Page 6 of 101 - Boston Life Sciences Times

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

October 15, 2026

Akamis Bio Completes Enrollment in Phase 1b Rectal Cancer Treatment Study

October 14, 2026

Mursla Bio Publishes Study Validating Tissue-Specific Liquid Biopsy Technology

October 13, 2026

THIS WEEK'S STORIES

Charles River Laboratories Partners With Magellan Stem Cells to Advance Osteoarthritis Cell Therapy

October 13, 2026

MindWalk Strengthens Boston Leadership Team as Drug Development Pipeline Advances

October 14, 2026

Marengo Therapeutics Receives Second FDA Fast Track Designation for Cancer Immunotherapy

October 15, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Takeda Launches Narcolepsy Drug ORZEYFUL in Japan and China, U.S. Launch Planned

Takeda Reports Positive Phase 2/3 Results for Experimental Immunodeficiency Treatment

Calluna Pharma Completes Dosing in Phase 2 Lung Fibrosis Trial, Expects Results in Early 2027

Alkermes to Present New Narcolepsy and Sleep Disorder Treatment Data at Sleep Europe 2026

Scholar Rock Resubmits European Application for Spinal Muscular Atrophy Treatment

Most Read

Perceptive Discovery Expands Radiopharmaceutical Research Capabilities in Massachusetts and UK

Boston-Based Clasp Launches Healthcare Job Marketplace Offering Student Loan Repayment Benefits

Ironwood Pharmaceuticals Names Tammi Gaskins CEO as Tom McCourt Announces Retirement

Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease

EDITOR PICKS